Bayer making deep inroads across China

 06-May-15, China Daily

Bayer HealthCare reaffirmed its leading position in China's healthcare industry with sales of some 1.66 billion euros ($1.85 billion) in the country last year, a 14 percent growth from 2013.

Image: China Daily

At a recent press conference in Beijing, the company said its pharmaceuticals business grew at an annual rate of 15 percent in China, with a 26 percent spike in its consumer care business and 11 percent growth in its animal healthcare division.

"Our success in China is based on our company's innovation capabilities and patient-focused treatment options," said Alok Kanti, managing director of Bayer HealthCare China. "As people age and as the economy becomes industrialized, disease profiles change," he said. "Despite existing technologies, there is a higher amount of unmet needs."

 Read the full article 

 Insights